A detailed history of Goldman Sachs Group Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Goldman Sachs Group Inc holds 12,710,302 shares of BMY stock, worth $734 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
12,710,302
Previous 15,740,727 19.25%
Holding current value
$734 Million
Previous $654 Million 0.62%
% of portfolio
0.11%
Previous 0.11%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $120 Million - $157 Million
-3,030,425 Reduced 19.25%
12,710,302 $658 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $9.29 Million - $12.2 Million
-230,832 Reduced 1.45%
15,740,727 $654 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $18.6 Million - $21.1 Million
-387,977 Reduced 2.37%
15,971,559 $866 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $47.7 Million - $57 Million
-984,542 Reduced 5.68%
16,359,536 $839 Million
Q3 2023

May 14, 2024

BUY
$57.89 - $64.73 $57 Million - $63.7 Million
984,542 Added 6.02%
17,344,078 $1.01 Billion
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $48.6 Million - $54.4 Million
840,138 Added 5.09%
17,344,078 $1.01 Billion
Q2 2023

May 14, 2024

SELL
$63.71 - $70.74 $42.7 Million - $47.4 Million
-669,878 Reduced 3.9%
16,503,940 $1.06 Billion
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $42.7 Million - $47.4 Million
-669,878 Reduced 3.9%
16,503,940 $1.06 Billion
Q1 2023

May 14, 2024

BUY
$65.71 - $74.53 $96.6 Million - $110 Million
1,470,325 Added 9.36%
17,173,818 $1.19 Billion
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $96.6 Million - $110 Million
1,470,325 Added 9.36%
17,173,818 $1.19 Billion
Q4 2022

May 14, 2024

BUY
$68.48 - $81.09 $11.1 Million - $13.1 Million
162,073 Added 1.04%
15,703,493 $1.13 Billion
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $11.1 Million - $13.1 Million
162,073 Added 1.04%
15,703,493 $1.13 Billion
Q3 2022

May 14, 2024

BUY
$0.13 - $76.84 $153,961 - $91 Million
1,184,317 Added 8.25%
15,541,420 $1.1 Billion
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $153,961 - $91 Million
1,184,317 Added 8.25%
15,541,420 $1.1 Billion
Q2 2022

May 14, 2024

SELL
$72.62 - $79.98 $145 Million - $160 Million
-2,002,433 Reduced 12.24%
14,357,103 $1.11 Billion
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $127 Million - $140 Million
-1,751,823 Reduced 10.87%
14,357,103 $1.11 Billion
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $253 Million - $303 Million
4,114,062 Added 34.3%
16,108,926 $1.18 Billion
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $122 Million - $142 Million
-2,270,599 Reduced 15.92%
11,994,864 $748 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $844 Million - $989 Million
14,265,463 New
14,265,463 $844 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.